Genetic therapies represent a remarkable avenue for potentially slowing and preventing neurodegenerative diseases. This includes a first-in-human, gene-silencing treatment for Alzheimer’s disease. Find out more on this from Catherine Mummery.
Browsing: neurodegenerative disease
In this video, we spoke with Henrik Zetterberg to find out how challenges with replication, reproducibility and specificity could be addressed in the field.
Researchers have found that the sleep history and pattern of older men and women may predict the accumulation of proteins associated with Alzheimer’s disease.
To mark World Parkinson’s Day, we’re taking the opportunity to look back on some of the research highlights in the field over the last year.
Scientists have 3D printed a transparent skull implant for mice, creating a ‘window’ to the brain for monitoring brain surface activity in real time. The implant could provide unique opportunities for research into concussions as well as Alzheimer’s and Parkinson’s diseases.
For our Spotlight on biomarker discovery and development we carried out a survey to gain insights into biomarkers used, their challenges and future outlook.
In this report from Future Neurology, researchers describe the application and state of development of a range of CSF biomarkers in common neurodegenerative disorders.
Researchers have identified a simple blood test that may be able to diagnose neurodegeneration before symptoms arise; this could lead to earlier diagnosis of Alzheimer’s disease.
A new imaging study will be the first to use the GE180 ligand tracer to detect neuroinflammation in Parkinson’s and Alzheimer’s disease brains.
New studies reveal that exosomes transported between cells produce a wide-range of effects neurologically and throughout the body, from passing the effects of trauma onto the next generation to helping neurons communicate.